09.04.2024 • NewsRoquetteStart-upsInnovation

Roquette Invests in Danish Start-up Biograil

Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.

Copenhagen-based Biograil is developing a proprietary oral device called BIONDD for delivering biologics that would typically require injection. This advancement, Roquette said, is set to transform patient care by offering a less invasive and more accessible treatment method.

Biograil’s BIONDD device is contained in a standard size capsule able to deliver active therapeutics into the gastrointestinal wall to be effectively distributed in the human body.

With this investment, Roquette Ventures joined a consortium that also includes Megatrend Invest (Denmark), Verve Investment (Switzerland), High-Tech Gründerfonds (Germany), Sanner Ventures (Germany), Evonik Venture Capital (Germany) and Eli Lilly (US).

Roquette Ventures said it believes that this investment fits perfectly with its investment philosophy, which focuses on promoting solutions to improve health and sustainability. Furthermore, the Roquette group can contribute its expertise in pharmaceutical excipients, enhancing Biograil's efforts to advance their platform technology.

© Shutterstock / piotr_pabijan
© Shutterstock / piotr_pabijan

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read